Screening for AATD consists of quantifying A1A in the blood and, if the level of A1A is low, gel-electrophoresis-based protease inhibitor (PI) typing determines which SERPINA1 alleles are present. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.